Esther J.M. Schilder-Tol

959 total citations
14 papers, 612 citations indexed

About

Esther J.M. Schilder-Tol is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Esther J.M. Schilder-Tol has authored 14 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Esther J.M. Schilder-Tol's work include T-cell and B-cell Immunology (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Esther J.M. Schilder-Tol is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Esther J.M. Schilder-Tol collaborates with scholars based in Netherlands, Germany and United States. Esther J.M. Schilder-Tol's co-authors include Steven T. Pals, Monique E.C.M. Oud, Linda Smit, Arjan W. Griffioen, Jannie Borst, Jan Aten, Jan J. Weening, Marcel Spaargaren, Anja Roos and Nike Claessen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Esther J.M. Schilder-Tol

14 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther J.M. Schilder-Tol Netherlands 11 221 218 177 146 110 14 612
Lisa H. Butler United Kingdom 7 379 1.7× 147 0.7× 300 1.7× 252 1.7× 140 1.3× 8 783
Anouk Demunter Belgium 8 88 0.4× 109 0.5× 284 1.6× 196 1.3× 36 0.3× 9 515
Vadim Baykov Russia 11 118 0.5× 60 0.3× 163 0.9× 207 1.4× 57 0.5× 47 480
Claudiu Cotta United States 16 123 0.6× 126 0.6× 294 1.7× 133 0.9× 123 1.1× 50 638
Florence Armstrong France 10 129 0.6× 118 0.5× 290 1.6× 171 1.2× 82 0.7× 12 630
Ipatia Doussis-Anagnostopoulou Greece 12 230 1.0× 150 0.7× 219 1.2× 274 1.9× 35 0.3× 22 562
TE Witzig United States 10 190 0.9× 221 1.0× 322 1.8× 307 2.1× 232 2.1× 13 795
Antony C. Cambareri Australia 12 64 0.3× 229 1.1× 204 1.2× 181 1.2× 342 3.1× 14 885
TW Mak Canada 9 290 1.3× 292 1.3× 144 0.8× 198 1.4× 200 1.8× 13 671
J Dumont France 12 207 0.9× 95 0.4× 151 0.9× 224 1.5× 145 1.3× 35 595

Countries citing papers authored by Esther J.M. Schilder-Tol

Since Specialization
Citations

This map shows the geographic impact of Esther J.M. Schilder-Tol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther J.M. Schilder-Tol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther J.M. Schilder-Tol more than expected).

Fields of papers citing papers by Esther J.M. Schilder-Tol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther J.M. Schilder-Tol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther J.M. Schilder-Tol. The network helps show where Esther J.M. Schilder-Tol may publish in the future.

Co-authorship network of co-authors of Esther J.M. Schilder-Tol

This figure shows the co-authorship network connecting the top 25 collaborators of Esther J.M. Schilder-Tol. A scholar is included among the top collaborators of Esther J.M. Schilder-Tol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther J.M. Schilder-Tol. Esther J.M. Schilder-Tol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Slot, Linda M., Robbert Hoogeboom, Laura A. Smit, et al.. (2016). B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains. American Journal Of Pathology. 186(12). 3273–3284. 13 indexed citations
2.
Schilder-Tol, Esther J.M., Monique E.C.M. Oud, Esther A. Beuling, et al.. (2016). The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells. Haematologica. 102(3). 573–583. 14 indexed citations
3.
Kraan, Willem, Hugo M. Horlings, Esther J.M. Schilder-Tol, et al.. (2013). High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer Journal. 3(9). e139–e139. 139 indexed citations
4.
Maldegem, Febe van, Thera A.M. Wormhoudt, Monique E.C.M. Oud, et al.. (2012). Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment. Leukemia. 26(7). 1647–1653. 24 indexed citations
5.
Groen, Richard W.J., Monique E.C.M. Oud, Esther J.M. Schilder-Tol, et al.. (2008). Illegitimate WNT Pathway Activation by β-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies. Cancer Research. 68(17). 6969–6977. 38 indexed citations
6.
Heddema, Edou R., Yvonne Pannekoek, Koorosh Faridpooya, et al.. (2006). No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands. Leukemia Research. 30(10). 1305–1307. 56 indexed citations
7.
Schmidlin, Heike, Wendy Dontje, Fedde Groot, et al.. (2006). Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood. 108(12). 3792–3800. 19 indexed citations
8.
Roos, A., et al.. (2001). The immune dysregulatory compound mercuric chloride induces integrin‐mediated T‐lymphocyte adhesion. Immunology. 102(1). 31–38. 2 indexed citations
9.
Aten, Jan, Anja Roos, Nike Claessen, et al.. (2000). Strong and Selective Glomerular Localization of CD134 Ligand and TNF Receptor-1 in Proliferative Lupus Nephritis. Journal of the American Society of Nephrology. 11(8). 1426–1438. 94 indexed citations
10.
Voort, Robbert van der, Linda Smit, Robert M. J. Keehnen, et al.. (1999). Cross-talk Between CD44 and c-Met in B cells. Current topics in microbiology and immunology. 246. 31–38. 14 indexed citations
11.
Roos, Anja, Esther J.M. Schilder-Tol, Jan J. Weening, & Jan Aten. (1998). Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment. Journal of Leukocyte Biology. 64(4). 503–510. 25 indexed citations
12.
Roos, A., Esther J.M. Schilder-Tol, Meera Chand, Jan J. Weening, & Jan Aten. (1997). HgCl2 and IL4 differentially modify expression of major histocompatibility complex class II molecules RT1.B and RT1.D in B lymphocytes from Brown Norway and Lewis rats. Transplantation Proceedings. 29(3). 1675–1676. 3 indexed citations
13.
Claessen, Nike, et al.. (1997). Thiol Levels in CD134-Defined Subsets of Rat T Lymphocytes: Possible Implications for HgCl2-Induced Immune Dysregulation. Biochemical and Biophysical Research Communications. 240(2). 452–457. 8 indexed citations
14.
Smit, Linda, et al.. (1996). Signaling through CD44 Is Mediated by Tyrosine Kinases. Journal of Biological Chemistry. 271(5). 2863–2867. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026